Involvement of insulin-like growth factors-I and -II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas

被引:17
作者
Elizalde, PV
Lanari, C
Molinolo, AA
Guerra, FK
Balaña, ME
Simian, M
Iribarren, AM
Charreau, EH
机构
[1] Inst Biol & Med Expt, RA-1428 Buenos Aires, DF, Argentina
[2] Inst Invest Ingn Genet & Biol Mol, INGEBI, RA-1428 Buenos Aires, DF, Argentina
关键词
D O I
10.1016/S0960-0760(98)00123-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The role of the insulin-like growth factors (IGFs) system was investigated in hormone-dependent (HD) and -independent (HI) in vivo lines of the medroxyprogesterone acetate (MPA)-induced mammary tumor model in Balb/c mice. IGF-II protein and message showed a three- to four-fold increase in HD lines growing in MPA-treated mice, as compared with HD tumors growing in untreated mice. Progression to a hormone-independent phenotype in all these lines was accompanied by a high constitutive expression of IGF-II. Similar IGF-I mRNA levels were detected in HD and HI lines. Both IGF-I and -II messages arose from the malignant epithelial cells, as shown by in situ hybridization studies. A significant decrease in Man-6P/type II IGF-R content was detected in HD tumors growing in MPA-treated mice as compared with HD lines growing in untreated mice. On the other hand, in HI tumors, notwithstanding high IGF-II synthesis, the levels of Man-6P/type II IGF-R remain high. Competitive inhibition and affinity labeling studies showed an almost exclusive binding of IGF-II to Man-6P/type II IGF-R on tumor membranes. The involvement of IGFs in the growth of epithelial primary cultures of the C4-HD line was evaluated. Exogenous IGF-I potentiated MPA stimulatory effect at concentrations of 50-100 ng/ml. Treatment of C4-HD cells with antisense oligodeoxynucleotides (ASODNs) to type I IGF-R and to IGF-II RNA resulted in a dose-dependent inhibition of MPA-mediated cell proliferation. The inhibition caused by IGF-II ASODNs could not be overcome by the addition of IGF-II up to 150 ng/ml. ASODNs to type I IGF-R at 40 mu g/ml reduced by 75% the number of type I IGF-R; ASODNs to IGF-II at 1 mu M decreased by 83% the levels of IGF-II protein. Our results provide support for the involvement of IGF-I and -II in MPA-induced mammary tumor growth by autocrine pathways. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:305 / 317
页数:13
相关论文
共 52 条
[1]   STIMULATION OF ESTROGEN RECEPTOR-MEDIATED TRANSCRIPTION AND ALTERATION IN THE PHOSPHORYLATION STATE OF THE RAT UTERINE ESTROGEN-RECEPTOR BY ESTROGEN, CYCLIC ADENOSINE-MONOPHOSPHATE, AND INSULIN-LIKE GROWTH FACTOR-I [J].
ARONICA, SM ;
KATZENELLENBOGEN, BS .
MOLECULAR ENDOCRINOLOGY, 1993, 7 (06) :743-752
[2]   BLOCKADE OF THE TYPE-I SOMATOMEDIN RECEPTOR INHIBITS GROWTH OF HUMAN-BREAST CANCER-CELLS IN ATHYMIC MICE [J].
ARTEAGA, CL ;
KITTEN, LJ ;
CORONADO, EB ;
JACOBS, S ;
KULL, FC ;
ALLRED, DC ;
OSBORNE, CK .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (05) :1418-1423
[3]  
ARTEAGA CL, 1989, CANCER RES, V49, P6237
[4]   INSULIN-LIKE GROWTH FACTOR-BINDING PROTEINS IN HYPOPHYSECTOMIZED RAT-LIVER - CHARACTERIZATION AND SUBCELLULAR-LOCALIZATION [J].
BARENTON, B ;
PATEL, BA ;
KHAN, MN ;
GUYDA, HJ ;
POSNER, BI .
ENDOCRINOLOGY, 1988, 122 (06) :2499-2507
[5]  
BASERGA R, 1995, CANCER RES, V55, P249
[6]   [LEU27] INSULIN-LIKE GROWTH FACTOR-II IS HIGHLY SELECTIVE FOR THE TYPE-II IGF RECEPTOR IN BINDING, CROSS-LINKING AND THYMIDINE INCORPORATION EXPERIMENTS [J].
BEUKERS, MW ;
OH, Y ;
ZHANG, HP ;
LING, N ;
ROSENFELD, RG .
ENDOCRINOLOGY, 1991, 128 (02) :1201-1203
[7]   EFFECT OF ENDOCRINE THERAPY ON GROWTH OF T61 HUMAN BREAST-CANCER XENOGRAFTS IS DIRECTLY CORRELATED TO A SPECIFIC DOWN-REGULATION OF INSULIN-LIKE GROWTH FACTOR-II (IGF-II) [J].
BRUNNER, N ;
YEE, D ;
KERN, FG ;
SPANGTHOMSEN, M ;
LIPPMAN, ME ;
CULLEN, KJ .
EUROPEAN JOURNAL OF CANCER, 1993, 29A (04) :562-569
[8]   IGF-I AND IGF-II EXPRESSION IN HUMAN BREAST-CANCER XENOGRAFTS - RELATIONSHIP TO HORMONE INDEPENDENCE [J].
BRUNNER, N ;
MOSER, C ;
CLARKE, R ;
CULLEN, K .
BREAST CANCER RESEARCH AND TREATMENT, 1992, 22 (01) :39-45
[9]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[10]   REGULATION OF PROGESTERONE-RECEPTOR GENE-EXPRESSION IN MCF-7 BREAST-CANCER CELLS - A COMPARISON OF THE EFFECTS OF CYCLIC ADENOSINE-3',5'-MONOPHOSPHATE, ESTRADIOL, INSULIN-LIKE GROWTH FACTOR-I, AND SERUM FACTORS [J].
CHO, HS ;
ARONICA, SM ;
KATZENELLENBOGEN, BS .
ENDOCRINOLOGY, 1994, 134 (02) :658-664